Kurs Vortag | 76,32 |
Öffnen | 76,89 |
Gebot | 77,28 x 9000 |
Briefkurs | 77,46 x 30000 |
Tagesspanne | 76,47 - 77,75 |
52-Wochen-Spanne | 71,49 - 105,14 |
Volumen | |
Durchschn. Volumen | 3.442 |
Marktkap. | 103,102B |
Beta (5 J., monatlich) | 0,72 |
Kurs-Gewinn-Verhältnis (roll. Hochrechn.) | 26,19 |
EPS (roll. Hochrechn.) | 2,96 |
Gewinndatum | N/A |
Erwartete Dividende & Rendite | 2,50 (3,29%) |
Ex-Dividendendatum | 20. Dez. 2022 |
1-Jahres-Kursziel | N/A |
NORTHAMPTON, MA / ACCESSWIRE / November 9, 2022 / Medtronic In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company's ...
CECP's CEO Investor Forum, the only platform that brings CEOs and investors together to discuss Long-Term Plans, hosted three CEOs from the world's largest medtech companies-Abbott (NYSE:ABT), Medtronic (NYSE:MDT), and Intuitive Surgical (NASDAQ:ISRG).
Medtronic Stroke is a leading cause of death and disability around the world, but only a fraction of people who suffer a stroke get treatment in time.